my account  log out
 

Mifepristone

Create: 09/28/2016
Expired Date:09/30/2019
Category: Estrone [Health&Medical&Pharmaceutical]
Message: Mifepristone Molecular Formula:C29H35NO2 CAS Registry Number:84371-65-3 Synonyms:Estra-4,9-dien-3-one,11-[4-(dimethylamino)- phenyl]-17-hydroxy-17-(1-propynyl)-,(11a,- 17a)-; Mifepristone [USAN:BAN:INN]; 17-beta-Hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one; Mifeprex; Mifepristonum [Latin]; R 38486; RU 38486; 11beta-(4-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-on; Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)-, (11b,17b)-; Prestwick_570; Mifegyne; (11beta,17beta)-11-(4-(Dimethylamino)-phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one; RU-486; RU486; 11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-21-methyl-19-nor-17alpha-pregna-4,9-dien-20-m-3-on; RU 486-6; 17-(1-propynyl)estra-4,9-dien-3-one; Chemical Properties Appearance:Pale Yellow Solid Molecular Weight:429.5937 Density:1.18 g/cm3 Boiling Point:628.6 °C at 760 mmHg Melting Point:195-198°C Flash Point:334 °C Storage Temperature:2-8°C Refractive index:1.623 Solubility:Soluble to 100 mM in DMSO and to 50 mM in Ethanol Biological Activity:Selective antagonist at progesterone (PR) and glucocorticoid (GR) receptors in vitro and in vivo . Is a silent antagonist at PR and has a higher affinity than progesterone. Has higher affinity for GR than dexamethasone. Stability:Stable at normal temperatures and pressures. Usage:A progesterone receptor antagonist with partial agonist activity. Abortifacient. For more details, please contact cindy1114@yccreate.com
City:Wuhan Hubei[CN] 
Location:
 
Sep 29 20163,6-Dichloropyridazine353
Sep 29 2016Cephalomannine357
Sep 29 2016 Notoginseng Triterpenes363
Sep 29 2016 Xanthophyll from alfalfa370
Sep 29 2016 Escin387
Sep 29 2016Eugenol365
Sep 29 2016Scopolamine Butylbromide364
Sep 29 2016 Caryophyllene362
Sep 29 2016 L(-)-Menthol362
Sep 29 2016DHA Powder Schizochytrium346

return back

Copyright © toextrade Inc. All rights reserved. Contact us